The chemical class of GPR37L1 activators is an intriguing and diverse group of compounds characterized by their interaction with cellular signaling pathways and molecular processes that influence the activity of the G-protein-coupled receptor GPR37L1. This group encompasses a variety of chemical structures and functions, ranging from organic compounds like polyphenols to bioactive lipids and synthetic molecules. These activators do not directly bind to GPR37L1 but are implicated in modulating the receptor's activity through indirect mechanisms. For instance, polyphenolic compounds such as Resveratrol and Quercetin are known to interact with a wide range of GPCRs, suggesting an influence on GPR37L1 through modulation of the receptor's signaling environment. The action of these molecules can alter downstream signaling pathways, which in turn might affect the function of GPR37L1. Such interactions exemplify the complex interplay between these activators and GPCR signaling pathways.
In addition to polyphenols, this class includes compounds like Forskolin, a diterpene known for its ability to increase intracellular cAMP levels, and GTPγS, a GTP analog instrumental in G-protein signaling. These molecules are crucial in regulating the signaling pathways associated with GPCRs, including GPR37L1. By modulating second messengers like cAMP or influencing G-protein activation, they indirectly affect the activity of GPR37L1. Furthermore, the group incorporates bioactive lipids such as Sphingosine-1-phosphate and Lysophosphatidic acid, which are involved in complex lipid signaling pathways and may intersect with GPR37L1's function. Cholesterol, essential for the structural integrity of GPCRs, also plays a role in this class by affecting the receptor's microenvironment and operational dynamics. Collectively, these activators represent a multifaceted chemical landscape, exerting their influence through a network of signaling pathways and molecular interactions that converge on the modulation of GPR37L1 activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
This polyphenol can modulate G-protein-coupled receptor signaling, potentially influencing GPR37L | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels, which may impact GPR37L1 signaling pathways. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $456.00 | ||
A GTP analog, can activate G-protein signaling, potentially affecting GPR37L1 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Involved in lipid signaling pathways that could intersect with GPR37L1's function. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
A flavonoid that can modulate various GPCR pathways, possibly influencing GPR37L | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
As a general GPCR activator, it may indirectly affect GPR37L1 activity through downstream signaling. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Its action on dopamine receptors can indirectly affect GPR37L1 through modulated signaling pathways. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
Essential for GPCR function, it can modulate GPR37L1's environment and potentially its activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
As a lipid mediator, it can influence GPCR-mediated pathways, potentially affecting GPR37L | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A non-selective beta-adrenergic agonist, could indirectly modulate GPR37L1 through cAMP pathways. |